Clinical Trials in Nashville

Showing 6081-6100 of 20,298 trials

A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

NCT05039177

* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advanced GI malignancies. * To determine the Maximum Tolerated Dose (MTD) and/or Recommended Dose (RD) of ERAS-007 administered in combination with other cancer therapies. * To evaluate the antitumor activity of ERAS-007 in combination with other cancer therapies. * To evaluate the PK profiles of ERAS-007 and other cancer therapies when administered in combination.

Metastatic Colorectal CancerMetastatic Pancreatic Ductal Adenocarcinoma

Erasca, Inc.102 participantsStarted Sep 2021

Birmingham, Alabama, United States • Duarte, California, United States • Orange, California, United States +11 more locations

COMPLETEDNA< 1 mile

Computerized Memory Enhancing Treatment in MCI

NCT05332522

The investigators propose to apply neuroplasticity-based computerized cognitive remediation (nCCR) to improve memory function in patients with Mild Cognitive Impairment (MCI).

Mild Cognitive Impairment

Vanderbilt University Medical Center19 participantsStarted Aug 2022

Nashville, Tennessee, United States

A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

Computerized Memory Enhancing Treatment in MCI

Find Trials by Condition in Nashville

A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors

A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants

Open-Label Study of Setmelanotide in Hypothalamic Obesity

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

A Study of SGN-ALPV in Advanced Solid Tumors

Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.

A Study of Imvotamab in Severe Systemic Lupus Erythematosus

A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis

A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel

Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease